227 related articles for article (PubMed ID: 11448786)
1. Cystic fibrosis: the 'bicarbonate before chloride' hypothesis.
Wine JJ
Curr Biol; 2001 Jun; 11(12):R463-6. PubMed ID: 11448786
[TBL] [Abstract][Full Text] [Related]
2. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.
Wilschanski M; Zielenski J; Markiewicz D; Tsui LC; Corey M; Levison H; Durie PR
J Pediatr; 1995 Nov; 127(5):705-10. PubMed ID: 7472820
[TBL] [Abstract][Full Text] [Related]
3. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.
Al-Mendalawi MD; Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
Saudi Med J; 2010 Mar; 31(3):339-40; author reply 340. PubMed ID: 20231949
[No Abstract] [Full Text] [Related]
4. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
Reddy MM; Quinton PM
JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
[TBL] [Abstract][Full Text] [Related]
5. Sweat chloride and immunoreactive trypsinogen in infants carrying two
Castellani C; Tridello G; Tamanini A; Assael BM
Arch Dis Child; 2017 Jul; 102(7):644-646. PubMed ID: 26755536
[TBL] [Abstract][Full Text] [Related]
6. Correlation of sweat chloride concentration with genotypes in cystic fibrosis patients in Saguenay Lac-Saint-Jean, Quebec, Canada.
De Braekeleer M; Allard C; Leblanc JP; Aubin G; Simard F
Clin Biochem; 1998 Feb; 31(1):33-6. PubMed ID: 9559222
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of direct bicarbonate transport by the CFTR anion channel.
Tang L; Fatehi M; Linsdell P
J Cyst Fibros; 2009 Mar; 8(2):115-21. PubMed ID: 19019741
[TBL] [Abstract][Full Text] [Related]
8. CFTR-dependent chloride efflux in cystic fibrosis mononuclear cells is increased by ivacaftor therapy.
Guerra L; D'Oria S; Favia M; Castellani S; Santostasi T; Polizzi AM; Mariggiò MA; Gallo C; Casavola V; Montemurro P; Leonetti G; Manca A; Conese M
Pediatr Pulmonol; 2017 Jul; 52(7):900-908. PubMed ID: 28445004
[TBL] [Abstract][Full Text] [Related]
9. A molecular mechanism for aberrant CFTR-dependent HCO(3)(-) transport in cystic fibrosis.
Ko SB; Shcheynikov N; Choi JY; Luo X; Ishibashi K; Thomas PJ; Kim JY; Kim KH; Lee MG; Naruse S; Muallem S
EMBO J; 2002 Nov; 21(21):5662-72. PubMed ID: 12411484
[TBL] [Abstract][Full Text] [Related]
10. Bicarbonate Transport in Cystic Fibrosis and Pancreatitis.
Angyal D; Bijvelds MJC; Bruno MJ; Peppelenbosch MP; de Jonge HR
Cells; 2021 Dec; 11(1):. PubMed ID: 35011616
[TBL] [Abstract][Full Text] [Related]
11. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
[TBL] [Abstract][Full Text] [Related]
12. Bicarbonate secretion and CFTR: continuing the paradigm shift.
Ulrich CD
Gastroenterology; 2000 Jun; 118(6):1258-61. PubMed ID: 10833500
[No Abstract] [Full Text] [Related]
13. Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis.
Choi JY; Muallem D; Kiselyov K; Lee MG; Thomas PJ; Muallem S
Nature; 2001 Mar; 410(6824):94-7. PubMed ID: 11242048
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis transmembrane conductance regulator currents in guinea pig pancreatic duct cells: inhibition by bicarbonate ions.
O'Reilly CM; Winpenny JP; Argent BE; Gray MA
Gastroenterology; 2000 Jun; 118(6):1187-96. PubMed ID: 10833494
[TBL] [Abstract][Full Text] [Related]
15. CFTR pharmacology.
Zegarra-Moran O; Galietta LJ
Cell Mol Life Sci; 2017 Jan; 74(1):117-128. PubMed ID: 27704174
[TBL] [Abstract][Full Text] [Related]
16. Bicarbonate in cystic fibrosis.
Kunzelmann K; Schreiber R; Hadorn HB
J Cyst Fibros; 2017 Nov; 16(6):653-662. PubMed ID: 28732801
[TBL] [Abstract][Full Text] [Related]
17. Gating of CFTR by the STAS domain of SLC26 transporters.
Ko SB; Zeng W; Dorwart MR; Luo X; Kim KH; Millen L; Goto H; Naruse S; Soyombo A; Thomas PJ; Muallem S
Nat Cell Biol; 2004 Apr; 6(4):343-50. PubMed ID: 15048129
[TBL] [Abstract][Full Text] [Related]
18. Identification of transport abnormalities in duodenal mucosa and duodenal enterocytes from patients with cystic fibrosis.
Pratha VS; Hogan DL; Martensson BA; Bernard J; Zhou R; Isenberg JI
Gastroenterology; 2000 Jun; 118(6):1051-60. PubMed ID: 10833480
[TBL] [Abstract][Full Text] [Related]
19. Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype.
McKone EF; Velentgas P; Swenson AJ; Goss CH
J Cyst Fibros; 2015 Sep; 14(5):580-6. PubMed ID: 25660278
[TBL] [Abstract][Full Text] [Related]
20. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
Soultan ZN; Foster MM; Newman NB; Anbar RD
J Pediatr; 2008 Dec; 153(6):857-9. PubMed ID: 19014821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
